Search

Author/Creator Kozelj, Matic

1. Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label. Issue 1 (January 2021)

Authors:
Stefanovic, Sebastian; Detrez, Iris; Compernolle, Griet; Brouwers, Els; Sever, Nejc; Stabuc, Borut; Smrekar, Natasa; Kurent, Tina; Novak, Gregor; Kozelj, Matic; Ferrante, Marc; Gils, Ann; Drobne, David
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 33:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Success and safety of high infliximab trough levels in inflammatory bowel disease. (3rd August 2018)

Authors:
Drobne, David; Kurent, Tina; Golob, Sasa; Svegl, Polona; Rajar, Polona; Terzic, Sara; Kozelj, Matic; Novak, Gregor; Smrekar, Natasa; Plut, Samo; Sever, Nejc; Strnisa, Luka; Hanzel, Jurij; Brecelj, Jernej; Urlep, Darja; Osredkar, Josko; Homan, Matjaz; Orel, Rok; Stabuc, Borut; Ferkolj, Ivan
Journal:
Scandinavian journal of gastroenterology
Issue:
Volume 53:Number 8(2018)
Page Start:
940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗